R&D | May 12, 2026
Laser-based framework to precisely control liquid droplets
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
This is an exciting and meaningful milestone for GRIN Therapeutics
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
Health innovations are viewed more positively than food and agricultural technologies
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The company allocated €56 million to research and development for next-generation line solutions
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
